 | ASLAN Pharmaceuticals Limited | |||
| NCM : ASLN || Location: Singapore | ||||
$0.46-0.06 (-11.13%) |
11.36 M | 0.43 - 0.61 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.117 M |
| March 15, 2024 | 0.291 M |
| Feb. 29, 2024 | 0.019 M |
| Feb. 15, 2024 | 0.031 M |
| Jan. 31, 2024 | 0.059 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 09/30/2023 | -0.80 | -0.56 | 29.61% |
| 06/30/2023 | -0.82 | -0.11 | 86.52% |
| 03/31/2023 | -4.13 | -1.29 | 68.77% |
| 12/31/2022 | -0.91 | -1.04 | -14.56% |
| 09/30/2022 | -0.95 | -0.80 | 15.80% |
ASLN Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 22.627M | Shares Float | 22.627M |
| Short Float | 0.117M | Market Cap | 10.41M |
| Institution ownership | 15.49% | Insider ownership | 0.054% |
| Earnings Date | 04/26/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -2.75 | Forward EPS | -2.42 |